• About Us
  • Our Team
  • Platform Technologies
  • News
  • Contact
January 1 2015

January 2015: Accelero Biostructures, Inc. is founded with help from the University of California’s QB3 program

San Francisco: January 2015

Accelero Biostructures, Inc. is founded with help from the University of California’s QB3 program

Structure of Liver Receptor Homolog-1 (NR5A2) with PIP3 hormone bound in the ligand binding pocket. Sept. 2016: Accelero Biostructures, Inc. has received non-dilutive funding from the National Institutes of Health (NIH) under the Small Business Innovation Research (SBIR) Phase I program

Related Posts

Media

May 2019: Accelero Biostructures, Inc. has received additional non-dilutive funding from the National Institutes of Health (NIH) under the Small Business Innovation Research (SBIR) Phase II program

Media

March 2019: Accelero Biostructures, Inc. expedites structure determinations for groundbreaking research expanding the DNA alphabet from 4 to 8 building blocks

Media

September 2018: Accelero Biostructures, Inc. expands operations to MBC Biolabs

Recent Posts

  • Crystal Structure and Activity Studies of the C11 Cysteine Peptidase from Parabacteroides merdae in the Human Gut Microbiome
  • PNT1 Is a C11 Cysteine Peptidase Essential for Replication of the Trypanosome Kinetoplast.
  • May 2019: Accelero Biostructures, Inc. has received additional non-dilutive funding from the National Institutes of Health (NIH) under the Small Business Innovation Research (SBIR) Phase II program
  • March 2019: Accelero Biostructures, Inc. expedites structure determinations for groundbreaking research expanding the DNA alphabet from 4 to 8 building blocks
  • September 2018: Accelero Biostructures, Inc. expands operations to MBC Biolabs

Recent Comments

    Archives

    • May 2019
    • September 2016
    • January 2015

    Categories

    • Media
    • Publication
    © 2016- Accelero Biostructures.
    All Rights Reserved.